Related Pages for COLPAL
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
COLPAL
Related News - COLPAL
COLPAL: Q2 REVENUE 16.92B RUPEES VS 15.2B (YOY); EST 17.34B
22 Oct 2026 04:38 PM
COLPAL: Q2 REVENUE 16.92B RUPEES VS 15.2B (YOY); EST 17.34B
COLPAL: Q2 SL NET PROFIT 3.42B RUPEES VS 3.28B (YOY); EST 3.7B
22 Oct 2026 04:38 PM
COLPAL: Q2 SL NET PROFIT 3.42B RUPEES VS 3.28B (YOY); EST 3.7B
COLPAL: Q2 EBITDA 4.73B RUPEES VS 4.65B (YOY), EST 5.18B; Q2 EBITDA MARGIN 27.99% VS 30.63% (YOY), EST 30%
22 Oct 2026 04:38 PM
COLPAL: Q2 EBITDA 4.73B RUPEES VS 4.65B (YOY), EST 5.18B; Q2 EBITDA MARGIN 27.99% VS 30.63% (YOY), EST 30%
COLGATE-PALMOLIVE (INDIA): CO DECLARES FIRST INTERIM DIVIDEND OF 24 RUPEES PER EQUITY SHARE FOR FY2026-27
22 Oct 2026 04:38 PM
COLGATE-PALMOLIVE (INDIA): CO DECLARES FIRST INTERIM DIVIDEND OF 24 RUPEES PER EQUITY SHARE FOR FY2026-27
Colgate : JPMorgan on Colgate Maintains Neutral with Target Price of ₹1,976 as demand recovery needs to become durable, crude-led inflation clouds FY27 margins, overseas operations add earnings volatility, and execution and earnings visibility remain key.
17 Sep 2026 09:00 AM
Colgate : JPMorgan on Colgate Maintains Neutral with Target Price of ₹1,976 as demand recovery needs to become durable, crude-led inflation clouds FY27 margins, overseas operations add earnings volatility, and execution and earnings visibility remain key.
Colgate-Palmolive: Company Considering Sale Of Popular Personal Care Brands Like Softsoap, Irish Spring, And Speed Stick - MC
12 Sep 2026 11:35 AM
Colgate-Palmolive: Company Considering Sale Of Popular Personal Care Brands Like Softsoap, Irish Spring, And Speed Stick - MC
Colgate-Palmolive: Goldman Sachs on Colgate-Palmolive India Maintains Sell with Target Price of ₹2,050 as growth will be driven by premiumisation and higher oral-care consumption, but rising advertising spends are expected to keep EBITDA growth below sales despite stable 69–70% gross margins.
18 Aug 2026 08:54 AM
Colgate-Palmolive: Goldman Sachs on Colgate-Palmolive India Maintains Sell with Target Price of ₹2,050 as growth will be driven by premiumisation and higher oral-care consumption, but rising advertising spends are expected to keep EBITDA growth below sales despite stable 69–70% gross margins.
Colgate-Palmolive India: JPMorgan on Colgate-Palmolive India Maintains Neutral with Target Price of ₹2,250 as premiumisation remains the biggest growth lever, with balanced growth expected across volume, pricing and product mix despite near-term margin moderation.
18 Aug 2026 08:55 AM
Colgate-Palmolive India: JPMorgan on Colgate-Palmolive India Maintains Neutral with Target Price of ₹2,250 as premiumisation remains the biggest growth lever, with balanced growth expected across volume, pricing and product mix despite near-term margin moderation.
Colgate-Palmolive: Citi on Colgate-Palmolive India Maintains Sell with Target Price of ₹2,000 as premiumisation and affordability support balanced growth, but margin trade-offs are likely to persist.
18 Aug 2026 08:56 AM
Colgate-Palmolive: Citi on Colgate-Palmolive India Maintains Sell with Target Price of ₹2,000 as premiumisation and affordability support balanced growth, but margin trade-offs are likely to persist.
Colgate-Palmolive: HSBC on Colgate-Palmolive India Maintains Hold with Target Price of ₹2,140 as Q1 sales and volume beat expectations, driven by premiumization and higher ad spending, though growth outlook remains unchanged.
30 Jul 2026 08:59 AM
Colgate-Palmolive: HSBC on Colgate-Palmolive India Maintains Hold with Target Price of ₹2,140 as Q1 sales and volume beat expectations, driven by premiumization and higher ad spending, though growth outlook remains unchanged.
Colgate-Palmolive: Nomura on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,550 as Q1 volume and sales beat estimates, signaling a strong recovery despite margin pressure from higher advertising spends.
30 Jul 2026 08:59 AM
Colgate-Palmolive: Nomura on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,550 as Q1 volume and sales beat estimates, signaling a strong recovery despite margin pressure from higher advertising spends.
Colgate-Palmolive: Jefferies on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,650 as strong topline growth, premiumization, innovation, and improving growth momentum outweigh temporary margin pressure.
30 Jul 2026 09:00 AM
Colgate-Palmolive: Jefferies on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,650 as strong topline growth, premiumization, innovation, and improving growth momentum outweigh temporary margin pressure.
Colgate-Palmolive: Company's Toothpaste Line Sees Strong Volume Growth in High-Single Digits
29 Jul 2026 11:47 AM
Colgate-Palmolive: Company's Toothpaste Line Sees Strong Volume Growth in High-Single Digits
COLGATE PALMOLIVE: Q1 SL NET PROFIT 3.43B RUPEES VS 3.2B (YOY); EST 3.45B
29 Jul 2026 11:44 AM
COLGATE PALMOLIVE: Q1 SL NET PROFIT 3.43B RUPEES VS 3.2B (YOY); EST 3.45B
COLGATE PALMOLIVE: Q1 EBITDA 4.83B RUPEES VS 4.53B (YOY); EST 4.82B || Q1 EBITDA MARGIN 30.4% VS 31.86% (YOY); EST 30.6%
29 Jul 2026 11:46 AM
COLGATE PALMOLIVE: Q1 EBITDA 4.83B RUPEES VS 4.53B (YOY); EST 4.82B || Q1 EBITDA MARGIN 30.4% VS 31.86% (YOY); EST 30.6%
KSOLVES INDIA: Q1 REVENUE 401M RUPEES VS 377M (YOY)
15 Jul 2026 11:45 AM
KSOLVES INDIA: Q1 REVENUE 401M RUPEES VS 377M (YOY)
Colpal: Co To Consider Q1 Results On July 29
15 Jul 2026 11:45 AM
Colpal: Co To Consider Q1 Results On July 29
Colgate-Palmolive (India): Citi on Colgate-Palmolive (India) Sell, Target Price ₹1,900 (cut from ₹2,050), citing balanced revenue growth, pricing gains offset by intense competition, and a lower valuation multiple due to weaker-than-expected medium-term earnings growth.
02 Jul 2026 08:56 AM
Colgate-Palmolive (India): Citi on Colgate-Palmolive (India) Sell, Target Price ₹1,900 (cut from ₹2,050), citing balanced revenue growth, pricing gains offset by intense competition, and a lower valuation multiple due to weaker-than-expected medium-term earnings growth.
Colgate-Palmolive: Citi maintains Sell on Colgate-Palmolive (India) with a Target Price of ₹2,050, citing a more balanced growth trajectory aided by a favorable base, return of pricing but constrained realizations due to competition, premiumization as the key growth driver, and continued margin trade-offs despite healthy gross margins.
17 Jun 2026 09:04 AM
Colgate-Palmolive: Citi maintains Sell on Colgate-Palmolive (India) with a Target Price of ₹2,050, citing a more balanced growth trajectory aided by a favorable base, return of pricing but constrained realizations due to competition, premiumization as the key growth driver, and continued margin trade-offs despite healthy gross margins.
Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.
10 Jun 2026 08:53 AM
Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.
